What, who and when? Incorporating a discrete choice experiment into an economic evaluation

Health Economics Review

Table 1 Medman trial data for respondents to the DCE survey

		All Medman trial participants (Intervention and control combined; N = 554)		P value^a
		Baseline	12-month follow-up
Costs
Costs	mean	1410.9	1422.895	0.85
Costs	SD	1252.87	1199.32	0.85
Difference in costs			11.995
Difference in costs			448.22
Outcomes
Appropriate treatment score	mean	4.25	4.33	0.11
Appropriate treatment score	SD	0.905	1.02	0.11
SF-6D Score	mean	0.72	0.72	0.99
SF-6D Score	SD	0.14	0.15	0.99
EQ-5D Score	mean	0.73	0.74	0.45
EQ-5D Score	SD	0.24	0.265	0.45
Satisfaction score	mean	42.63	46.52	<0.01
Satisfaction score	SD	9.67	16.55	<0.01

^aDifferences between baseline and 12-month follow-up were tested using paired t test statistics

ISSN: 2191-1991